Cancer Family
Lymphocytic Neoplasm
CI-CAN-00000223Explore in graph →
HematologicNon-malignant3,036 active trials72 approved drugs345 evidence items
- NCIt
- C7065
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000223Explore in graph →
Clinical trials
12,949 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00292695 | A Phase II Study of Nasal NK/T-cell Lymphoma | completed | Phase 2 | 33 | National Health Research Institutes, TaiwanOTHER | 1 | Oct 30, 2013 | clinicaltrials |
| NCT01361191 | Early Treatment Stratification Based on PET Scan Response to Chemotherapy in Patients With Diffuse Large B-cell Lymphoma(R-MEGACHOP) | completed | Phase 2 | 71 | Grupo Español de Linfomas y Transplante Autólogo de Médula ÓseaOTHER | 1 |
| Oct 30, 2013 |
| clinicaltrials |
| NCT00070187 | Immunotherapy Using Cyclosporine, Interferon Gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma | completed | Phase 2 / Phase 3 | 24 | Children's Oncology GroupNETWORK | 3 | Oct 17, 2013 | clinicaltrials |
| NCT00003356 | Rituximab Plus Interleukin-2 in Treating Patients With Lymphoma | completed | Phase 1 / Phase 2 | 58 | University of RochesterOTHER | 1 | Oct 16, 2013 | clinicaltrials |
| NCT00044551 | Evaluation of Bay 59-8862 in Patients With Aggressive, Refractory Non-Hodgkin's Lymphoma | completed | Phase 2 | 29 | BayerINDUSTRY | 6 | Oct 14, 2013 | clinicaltrials |
| NCT00079456 | Temsirolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma | completed | Phase 2 | 25 | National Cancer Institute (NCI)NIH | 1 | Oct 11, 2013 | clinicaltrials |
| NCT00006226 | Thalidomide in Treating Patients With Relapsed Chronic Lymphocytic Leukemia | completed | Phase 2 | 41 | National Cancer Institute (NCI)NIH | 1 | Oct 8, 2013 | clinicaltrials |
| NCT00016016 | Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Acute Leukemia | completed | Phase 1 / Phase 2 | 53 | National Cancer Institute (NCI)NIH | 1 | Oct 8, 2013 | clinicaltrials |
| NCT00100477 | Use of Topotecan in Patients With Refractory Acute Leukemia | completed | Phase 2 | 10 | US Department of Veterans AffairsFED | 1 | Sep 25, 2013 | clinicaltrials |
| NCT00547365 | Human Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart Dysfunction | completed | Phase 1 / Phase 2 | 10 | University of TennesseeOTHER | 1 | Sep 19, 2013 | clinicaltrials |
| NCT00048555 | Safety and Efficacy of IDEC-114 in Combination With Rituxan in the Treatment of Non-Hodgkin's Lymphoma | completed | Phase 1 / Phase 2 | 90 | BiogenINDUSTRY | 1 | Sep 16, 2013 | clinicaltrials |
| NCT00799136 | A Feasibility Study of Co-administering Combination Antiretroviral Therapy (cART) and R-EPOCH Chemotherapy for the Management of ARL(CATCH) | completed | Phase 2 | 6 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Sep 12, 2013 | clinicaltrials |
| NCT00575406 | Multicentre Study to Determine the Cardiotoxicity of R-CHOP Compared to R-COMP in Patients With Diffuse Large B-Cell Lymphoma(NHL-14) | completed | Phase 2 | 94 | Arbeitsgemeinschaft medikamentoese TumortherapieOTHER | 1 | Aug 30, 2013 | clinicaltrials |
| NCT00115193 | Pegfilgrastim Administered on the Same Day as Chemotherapy in Non-Hodgkin's Lymphoma | completed | Phase 2 | 77 | AmgenINDUSTRY | 0 | Aug 29, 2013 | clinicaltrials |
| NCT00026182 | Rituximab and Interleukin-12 in Treating Patients With B-Cell Non-Hodgkin's Lymphoma | completed | Phase 2 | 99 | National Cancer Institute (NCI)NIH | 1 | Aug 26, 2013 | clinicaltrials |
| NCT01109264 | Bendamustine Hydrochloride Injection for Initial Treatment of Chronic Lymphocytic Leukemia | completed | Phase 2 | 147 | Jiangsu Simcere Pharmaceutical Co., Ltd.INDUSTRY | 1 | Aug 23, 2013 | clinicaltrials |
| NCT00005609 | Rituximab in Treating Patients With Waldenstrom's Macroglobulinemia | completed | Phase 2 | — | Eastern Cooperative Oncology GroupNETWORK | 3 | Aug 16, 2013 | clinicaltrials |
| NCT01232712 | A Study to Assess the Safety and Efficacy of MUC1 Peptide Vaccine and hGM-CSF in Patients With MUC1-positive Tumor Malignancies | completed | Phase 1 / Phase 2 | 15 | Vaxil Therapeutics Ltd.INDUSTRY | 1 | Aug 9, 2013 | clinicaltrials |
| NCT00315757 | Study of Mapatumumab in Combination With Bortezomib (Velcade) and Bortezomib Alone in Subjects With Relapsed or Refractory Multiple Myeloma | completed | Phase 2 | 105 | Human Genome Sciences Inc.INDUSTRY | 4 | Aug 8, 2013 | clinicaltrials |
| NCT00094848 | Study of TRM-1 (TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL) | completed | Phase 2 | — | Human Genome Sciences Inc.INDUSTRY | 1 | Aug 2, 2013 | clinicaltrials |
| NCT00499343 | G-CSF Versus G-CSF Plus GM-CSF for Stem Cell Mobilization in NHL Patients | completed | Phase 2 | 84 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 2, 2013 | clinicaltrials |
| NCT00795886 | Rapamycin for Immunosuppression and B Cell Modulation Post Stem Cell Transplant for Acute Lymphoblastic Leukemia (ALL) | completed | Phase 2 | 63 | University of UtahOTHER | 1 | Jul 31, 2013 | clinicaltrials |
| NCT00795132 | Hematopoietic Cell Transplantation for Pediatric Patients With Hematologic Malignancies | completed | Phase 2 | 47 | University of UtahOTHER | 1 | Jul 30, 2013 | clinicaltrials |
| NCT00002635 | Aminocamptothecin in Treating Patients With T-cell Lymphoma | completed | Phase 2 | 12 | Yale UniversityOTHER | 1 | Jul 26, 2013 | clinicaltrials |
| NCT00006760 | Combination Chemotherapy in Treating Children With Refractory or Relapsed Hodgkin's Lymphoma | completed | Phase 2 | 66 | Children's Oncology GroupNETWORK | 3 | Jul 26, 2013 | clinicaltrials |
| NCT00070304 | Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma | completed | Phase 2 | 33 | Children's Oncology GroupNETWORK | 5 | Jul 26, 2013 | clinicaltrials |
| NCT00507442 | Phase 1/2 Study of VELCADE® in Combination With Other Drugs to Treat Previously Untreated Multiple Myeloma Patients(EVOLUTION) | completed | Phase 1 / Phase 2 | 158 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Jul 26, 2013 | clinicaltrials |
| NCT00054327 | Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer | completed | Phase 2 | 34 | Case Comprehensive Cancer CenterOTHER | 1 | Jul 24, 2013 | clinicaltrials |
| NCT00842595 | Efficacy , Safety of Treatment R NIMP for Relapsed Aggressive Lymphomas | completed | Phase 2 | 50 | French Innovative Leukemia OrganisationOTHER | 1 | Jul 24, 2013 | clinicaltrials |
| NCT01387841 | Effect of Yoga in Reducing Chemotherapy Induced Nausea and Vomiting | completed | Phase 2 | 120 | Bharath Charitable Cancer Hospital and InstituteOTHER | 1 | Jul 24, 2013 | clinicaltrials |
| NCT00059904 | Rituximab and Interleukin-2 in Treating Patients With Relapsed or Refractory Intermediate- or High-Grade Non-Hodgkin's Lymphoma | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00304005 | VNP40101M in Treating Patients With Richter Syndrome or Refractory or Relapsed Chronic Lymphocytic Leukemia or Other Lymphoproliferative Disorders | completed | Phase 1 / Phase 2 | 35 | Vion PharmaceuticalsINDUSTRY | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00089154 | Apolizumab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma | completed | Phase 2 | 32 | National Cancer Institute (NCI)NIH | 1 | Jul 16, 2013 | clinicaltrials |
| NCT00062296 | Epirubicin and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia | completed | Phase 2 | 5 | Fox Chase Cancer CenterOTHER | 1 | Jul 11, 2013 | clinicaltrials |
| NCT00021372 | Paclitaxel and Estramustine in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma | completed | Phase 2 | 25 | Fox Chase Cancer CenterOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00504504 | Rituximab and ABVD for Hodgkin's Patients | completed | Phase 2 | 85 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 9, 2013 | clinicaltrials |
| NCT01118845 | Study of SyB L-0501 in Combination With Rituximab to Treat Relapsed/Refractory Diffuse Large B-Cell Lymphoma | completed | Phase 2 | 63 | SymBio PharmaceuticalsINDUSTRY | 2 | Jul 4, 2013 | clinicaltrials |
| NCT00002697 | Combination Chemotherapy Plus Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 3, 2013 | clinicaltrials |
| NCT00002982 | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Older Patients With Refractory or Relapsed Intermediate-Grade Non-Hodgkin's Lymphoma | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 3, 2013 | clinicaltrials |
| NCT00002970 | 506U78 in Treating Patients With Refractory Hematologic Cancer | completed | Phase 2 | 148 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2013 | clinicaltrials |
| NCT01095926 | Pharmacokinetic Study of Doxorubicin in Children With Cancer(Doxo) | completed | Phase 2 | 101 | University Hospital MuensterOTHER | 4 | Jun 28, 2013 | clinicaltrials |
| NCT00002502 | Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 27, 2013 | clinicaltrials |
| NCT00004061 | Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic Cancer | completed | Phase 2 | 111 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00004132 | Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer | completed | Phase 2 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00005579 | Dolastatin 10 in Treating Patients With Indolent Lymphoma, Waldenstrom's Macroglobulinemia, or Chronic Lymphocytic Leukemia | completed | Phase 2 | — | University of VermontOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00002691 | Combination Chemotherapy in Treating Pediatric Patients With Stage III or IV Non-Hodgkin's Lymphoma | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 25, 2013 | clinicaltrials |
| NCT00003658 | Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Other B-cell Cancers | completed | Phase 2 | 60 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 25, 2013 | clinicaltrials |
| NCT00002515 | Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00003541 | Combination Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma | completed | Phase 1 / Phase 2 | 24 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00006019 | Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Oct 30, 2013source: clinicaltrials